Intellectual Property India Publishes Patent Application for '3A,4,5,6-Tetrahydro-1 H-Pyrazolo[3,4-C]Pyridin-7(7AH)-One Derivatives As Factor Xiia Inhibitors' Filed by Kalvista Pharmaceuticals Limited

MUMBAI, India, June 6 -- Intellectual Property India has published a patent application (202517046959 A) filed by Kalvista Pharmaceuticals Limited, Wiltshire, U.K., on May 15, for '3a,4,5,6-tetrahydro-1 h-pyrazolo[3,4-c]pyridin-7(7ah)-one derivatives as factor xiia inhibitors.'

Inventor(s) include Davie, Rebecca Louise; Evans, David Michael; North, Carl Leslie; Avery, Craig Alex; Ferrer Mallofre, Eric; and Smith, Sean Alan.

The application for the patent was published on June 6, under issue no. 23/2025.

According to the abstract released by the Intellectual Property India: "The present invention provides compounds of formula (I): Formula (I) compositions comprising such compounds; the use of such compounds in medicine; and methods of tre...